Do competing demands of physical illness in type 2 diabetes influence depression screening, documentation and management in primary care: a cross-sectional analytic study in Aboriginal and Torres Strait Islander primary health care settings

Table 3 Adjusted effects of select disease severity indicators on depression screening, documentation and antidepressant prescription†

Variables	Screened with formal tool			Documented Depression			Prescription of antidepressant drugs
	AOR	95% CI		AOR	95% CI		AOR	95% CI
Renal disease
No	Reference			Reference			Reference
Yes	0.21**	0.14	0.31	0.34**	0.15	0.75	0.69	0.37	1.29
ACR level
<=3.4	Reference			Reference			Reference
>3.4	0.16**	0.08	0.32	0.77	0.38	1.51	0.50	0.23	1.03
Diabetes treatment
No medication	Reference			Reference			Reference
Oral	0.37**	0.23	0.61	0.80	0.38	1.69	0.99	0.49	2.02
Insulin/insulin+oral	0.48**	0.30	0.78	1.13	0.45	2.83	1.61	0.59	4.33
HbA1c level
<=7.00%	Reference			Reference			Reference
>7.00%*	0.40**	0.23	0.68	0.51**	0.30	0.84	0.80	0.48	1.33
Total cholesterol
<=4.00 mmol1-1	Reference			Reference			Reference
>4.00 mmol 1-1	0.83	0.48	1.44	1.00	0.67	1.51	2.05	0.89	4.72
Hyperlipidaemia†
No	Reference			Reference			Reference
Yes	1.86	0.85	4.09	1.23	0.47	3.22	1.28	0.61	2.69

†adjusted for sex, age, BMI and overall delivery of scheduled services; only those disease severity indicators significant in the bi-variate analysis are included
*P<0.01; **P<0.001.

ISSN: 1752-4458